| Literature DB >> 33744921 |
Marianne C Kalff1, Mark I van Berge Henegouwen1, Suzanne S Gisbertz1.
Abstract
Textbook outcome for esophageal cancer surgery is a composite quality measure including 10 short-term surgical outcomes reflecting an uneventful perioperative course. Achieved textbook outcome is associated with improved long-term survival. This study aimed to update the original textbook outcome based on international consensus. Forty-five international expert esophageal cancer surgeons received a personal invitation to evaluate the 10 items in the original textbook outcome for esophageal cancer surgery and to rate 18 additional items divided over seven subcategories for their importance in the updated textbook outcome. Items were included in the updated textbook outcome if ≥80% of the respondents agreed on inclusion. In case multiple items within one subcategory reached ≥80% agreement, only the most inclusive item with the highest agreement rate was included. With a response rate of 80%, 36 expert esophageal cancer surgeons, from 34 hospitals, 16 countries, and 4 continents responded to this international survey. Based on the inclusion criteria, the updated quality indicator 'textbook outcome for esophageal cancer surgery' should consist of: tumor-negative resection margins, ≥20 lymph nodes retrieved and examined, no intraoperative complication, no complications Clavien-Dindo ≥III, no ICU/MCU readmission, no readmission related to the surgical procedure, no anastomotic leakage, no hospital stay ≥14 days, and no in-hospital mortality. This study resulted in an international consensus-based update of a quality measure, textbook outcome for esophageal cancer surgery. This updated textbook outcome should be implemented in quality assurance programs for centers performing esophageal cancer surgery, and could standardize quality measures used internationally.Entities:
Keywords: esophageal cancer; esophagectomy; textbook outcome
Year: 2021 PMID: 33744921 PMCID: PMC8275976 DOI: 10.1093/dote/doab011
Source DB: PubMed Journal: Dis Esophagus ISSN: 1120-8694 Impact factor: 3.429
Original and updated textbook outcome variables for esophageal cancer surgery
| Variables in original textbook outcome | Variables in updated textbook outcome |
|---|---|
| Complete resection according to the surgeon at the end of surgery | |
| Tumor-negative resection margins (R0) | Tumor-negative resection margins (R0) |
| ≥ 15 lymph nodes retrieved and examined | ≥ 20 lymph nodes retrieved and examined |
| No intraoperative complication | No intraoperative complication |
| No complication of ≥ CD II | No complication of ≥ CD III |
| No reintervention ≤30 days after surgery | |
| No anastomotic leakage (all ECCG grades) | |
| No ICU/MCU readmission ≤30 days after surgery | No ICU/MCU readmission |
| No hospital stay ≥21 days | No hospital stay ≥14 days |
| No in-hospital and no 30-day mortality | No in-hospital mortality |
| No hospital readmission ≤30 days after discharge | No readmission related to the surgical procedure |
CD, Clavien–Dindo; ECCG, Esophagectomy Complications Consensus Group; ICU, intensive care unit; MCU, medium care unit.
International survey items and respondents’ agreement percentages per item and subcategory
| Survey categories, subcategories, and items | Respondents’ agreement rate | |||
|---|---|---|---|---|
| Round 1 | Round 2 | |||
| Oncological quality | Radical resection according to the surgeon at the end of surgery | 72% (26/36) | ||
| Tumor-negative resection margins | 97% (35/36) | |||
|
|
| |||
| At least 15 lymph nodes retrieved and examined | 56% (20/36) | 28% (9/32) | ||
| At least 20 lymph nodes retrieved and examined | 61% (22/36) | 38% (12/32) | ||
| At least 25 lymph nodes retrieved and examined | 56% (20/36) | 34% (11/32) | ||
| General surgical complications | No intraoperative complication | 92% (33/36) | ||
|
|
| |||
| No complication of CD II or higher | 44% (16/36) | |||
| No complication of CD III or higher | 83% (30/36) | |||
| No complication of CD IV or V | 44% (16/36) | |||
| No re-intervention (surgical / endoscopic / radiologic) | 83% (30/36) | |||
|
|
| |||
| No ICU/MCU readmission | 72% (28/36) | 66% (21/32) | ||
| No ICU/MCU stay longer than 1 day | 25% (9/36) | 6% (2/32) | ||
| No ICU/MCU stay longer than 1 day and no ICU/MCU readmission | 44% (16/36) | 28% (9/32) | ||
|
|
| |||
| No readmission within 30 days after discharge | 81% (29/36) | |||
| No readmission related to the surgical procedure | 83% (30/36) | |||
| Post-esophagectomy complications | Pneumonia | 59% (25/36) | ||
| Atrial dysrhythmia | 42% (15/36) | |||
| Anastomotic stricture requiring dilatation <90 days after surgery | 61% (22/36) | |||
|
|
| |||
| No anastomotic leakage (all grades according to ECCG) | 86% (31/36) | |||
| No anastomotic leakage (grade 2 or higher according to ECCG) | 75% (27/36) | |||
| No anastomotic leakage (grade 3 according to ECCG) | 58% (21/36) | |||
| Length of hospital stay |
|
| ||
| No hospital stay longer than 10 days | 42% (15/36) | 34% (11/32) | ||
| No hospital stay longer than 14 days | 58% (21/36) | 47% (15/32) | ||
| No hospital stay longer than 21 days | 61% (22/36) | 19% (6/32) | ||
| Mortality |
|
| ||
| No in-hospital mortality | 89% (32/36) | |||
| No 30-day mortality | 78% (28/36) | |||
| No in-hospital and no 30-day mortality | 86% (31/36) | |||
| No 90-day mortality | 81% (29/36) | |||
†Items (n = 10) in original version of textbook outcome for gastro-esophageal cancer. Text in italics indicate subcategories of resembling items. Values in italics indicate agreement on inclusion of items from the subcategories.
Fig. 1Worldwide distribution of survey respondents.
Fig. 2Overview of experience years and personal volume of responding surgeons.